KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma

Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .

NCT04234620 ·Status: UNKNOWN

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

NCT06697301 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma

NCT05478473 ·Status: UNKNOWN ·Phase: NA

The Combination of Anti-PD-1 With Radiotherapy in Previously Untreated Metastatic Melanoma

NCT04017897 ·Status: UNKNOWN ·Phase: PHASE2

A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma

NCT07099430 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma

NCT02738489 ·Status: COMPLETED ·Phase: PHASE1

Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

NCT06965231 ·Status: RECRUITING ·Phase: PHASE2

Toripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant Melanoma

NCT05087602 ·Status: UNKNOWN ·Phase: PHASE2

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

NCT04935229 ·Status: TERMINATED ·Phase: PHASE1

Duration of Anti-PD-1 Therapy in Metastatic Melanoma

NCT02821013 ·Status: RECRUITING ·Phase: PHASE3

A Clinical Study of T3011 in Subjects With Advanced Melanoma

NCT06214156 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

NCT04472806 ·Status: UNKNOWN ·Phase: PHASE2

X4P-001 and Pembrolizumab in Patients With Advanced Melanoma

NCT02823405 ·Status: COMPLETED ·Phase: PHASE1

Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma

NCT04248387 ·Status: UNKNOWN ·Phase: PHASE2

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

NCT02983006 ·Status: COMPLETED ·Phase: PHASE1

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

NCT06975293 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma

NCT04653038 ·Status: TERMINATED ·Phase: PHASE1

A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma

NCT01067066 ·Status: TERMINATED ·Phase: PHASE1

A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

NCT04756934 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)

NCT02821000 ·Status: COMPLETED ·Phase: PHASE1

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

NCT06327698 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut

NCT05274438 ·Status: UNKNOWN ·Phase: PHASE2

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

NCT01656642 ·Status: COMPLETED ·Phase: PHASE1

TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer

NCT05190575 ·Status: COMPLETED ·Phase: PHASE2

CP-675,206 In Patients With Advanced Melanoma

NCT00086489 ·Status: COMPLETED ·Phase: PHASE2